MARKET

NEO

NEO

Neogenomics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

33.81
+0.03
+0.07%
Opening 11:18 01/29 EST
OPEN
34.11
PREV CLOSE
33.78
HIGH
34.22
LOW
33.59
VOLUME
155.78K
TURNOVER
--
52 WEEK HIGH
34.44
52 WEEK LOW
16.04
MARKET CAP
3.52B
P/E (TTM)
1931.71
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NEO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NEO News

  • The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut
  • Benzinga.2h ago
  • First Analysis Downgrades NeoGenomics to Outperform, Announces $35 Price Target
  • Benzinga.6d ago
  • 2020 OUTLOOK AND INSIGHTS: Investment Trends and Themes to be Highlighted at the Emerald Groundhog Day Investment Forum
  • Business Wire.01/17 15:45
  • The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics
  • Benzinga.01/16 12:22

More

Industry

Healthcare Facilities & Services
+0.03%
Healthcare Providers & Services
-0.55%

Hot Stocks

Name
Price
%Change

About NEO

NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include Cytogenetics, Fluorescence In-Situ Hybridization (FISH), Flow cytometry, Immunohistochemistry (IHC), Molecular testing and Pathology consultation. Its Pharma Services and Clinical Trials group provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. It helps its customers develop a biomarker hypothesis by recommending an optimal platform for molecular screening and backing its discovery tools with the informatics to capture meaningful data.
More

Webull offers NeoGenomics, Inc. (NEO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.